Literature DB >> 10913839

Role of alpha-helical conformation of histatin-5 in candidacidal activity examined by proline variants.

H Situ1, S V Balasubramanian, L A Bobek.   

Abstract

Human salivary histatin-5 (Hsn-5) is a potent in vitro anticandidal agent. The aim of this study was to investigate the importance of alpha-helical structure of Hsn-5 for its candidacidal activity. The following three Hsn-5 variants, where one or more functionally nonessential residues were replaced with proline (potent alpha-helix breaker), were produced by Escherichia coli expression system: H21P (1P), H19P/H21P (2P), and E16P/H19P/H21P (3P). The activities of purified proteins were determined by candidacidal assays, and the secondary structures by circular dichroism (CD) spectroscopy in trifluoroethanol (TFE) that is considered the helix-promoting solvent, and lysophosphatidyl-glycerol (LPG) micelles, the environment that more closely resembles the biological membranes. Our results indicated that 3P variant displayed a candidacidal activity which was similar to that of unaltered Hsn-5 (0P), while 1P and 2P variants showed lower cidal activity. The CD spectra in TFE indicated that 3P variant has less helical characteristics than the 0P, 1P and 2P. These results suggested that the alpha-helical content of Hsn-5 proline variants does not correlate with the candidacidal activity. Further, the CD spectral analysis of peptides in LPG micelles indicated the formation of beta-turn structures in 0P and 3P variants. In conclusion, 3P variant which exhibited comparable candidacidal activity to 0P contains lower percentage of alpha-helical structure than 1P and 2P variants, which exhibited lower candidacidal activity. This suggests alpha-helix may not be important for anticandidal activity of Hsn-5.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913839     DOI: 10.1016/s0304-4165(00)00096-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.

Authors:  D M Rothstein; P Spacciapoli; L T Tran; T Xu; F D Roberts; M Dalla Serra; D K Buxton; F G Oppenheim; P Friden
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 2.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  How does it kill?: understanding the candidacidal mechanism of salivary histatin 5.

Authors:  Sumant Puri; Mira Edgerton
Journal:  Eukaryot Cell       Date:  2014-06-20

4.  Engineering improved variants of the antifungal peptide histatin 5 with reduced susceptibility to Candida albicans secreted aspartic proteases and enhanced antimicrobial potency.

Authors:  Svetlana P Ikonomova; Parisa Moghaddam-Taaheri; Mary Ann Jabra-Rizk; Yan Wang; Amy J Karlsson
Journal:  FEBS J       Date:  2017-11-29       Impact factor: 5.542

5.  Histatin 5 uptake by Candida albicans utilizes polyamine transporters Dur3 and Dur31 proteins.

Authors:  Rohitashw Kumar; Sonia Chadha; Darpan Saraswat; Jashanjot Singh Bajwa; Rui A Li; Heather R Conti; Mira Edgerton
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

6.  Dynamical Oligomerisation of Histidine Rich Intrinsically Disordered ProteinS Is Regulated through Zinc-Histidine Interactions.

Authors:  Carolina Cragnell; Lasse Staby; Samuel Lenton; Birthe B Kragelund; Marie Skepö
Journal:  Biomolecules       Date:  2019-04-30

7.  Effects of histatin 5 modifications on antifungal activity and kinetics of proteolysis.

Authors:  Svetlana P Ikonomova; Parisa Moghaddam-Taaheri; Yan Wang; Mary T Doolin; Kimberly M Stroka; Bernhard Hube; Amy J Karlsson
Journal:  Protein Sci       Date:  2019-11-20       Impact factor: 6.725

8.  Human antimicrobial peptides and proteins.

Authors:  Guangshun Wang
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-13

Review 9.  Envisaging Antifungal Potential of Histatin 5: A Physiological Salivary Peptide.

Authors:  Pratibha Sharma; Mehak Chaudhary; Garima Khanna; Praveen Rishi; Indu Pal Kaur
Journal:  J Fungi (Basel)       Date:  2021-12-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.